GPX4 and colorectal carcinoma: Additionally, the n‐3 PUFA and butyrate combination inhibits CRC development by weakening mitochondrial antioxidant defenses and promoting mitochondrial GPX4‐dependent ferroptosis (Chapkin et al. 2020).